CRDC Stock UPDATES Cardica Inc (CRDC) 1.03 08/02/2014 14:45:

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2014 at 3:45 PM

Cardica Inc (CRDC) 1.03 $CRDC

Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014
PR Newswire - Wed Jul 23, 7:00AM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal fourth quarter and year ended June 30, 2014, on Thursday, August 7, 2014, after the markets close. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

Cardica Announces Data Presentation At Amazing Technologies Session Of 14th Annual World Congress Of Endoscopic Surgery
PR Newswire - Mon Jun 30, 12:02PM CDT
Cardica, Inc. (Nasdaq: CRDC) today announced that Dr. Stefanos Demertzis, associate professor at the University of Berne, Switzerland and senior staff cardiac surgeon and deputy head of the department of cardiac surgery at the Cardiocentro Ticino Lugano, completed a study that demonstrated that there was no difference in the chronic healing response between the innovative D-shaped staple design of the Cardica five-millimeter MicroCutter XCHANGE® 30 and the B-shaped staple design used in conventional 12-millimeter surgical staplers.

NICE Guidelines to Boost Boston Scientific's Rhythm Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 2:00PM CDT
The new guidance released by NICE on use of cardiac technologies for arrhythmias and heart failure is expected to boost Boston Scientific Corporation's (BSX) Rhythm Management business in Europe.

Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 27, 1:55PM CDT
On Jun 27, 2014, we issued an updated research report on Haemonetics Corporation (HAE).

Medtronic's Cardiac Monitor Boosts AF Detection in Stroke Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 2:30PM CDT
Medtronic's (MDT) Reveal Insertable Cardiac Monitor possesses an algorithm to automatically detect AF as well as other cardiac arrhythmias.

Allscripts Healthcare's Sunrise EHR Platform Expansion on Track - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 1:20PM CDT
Since Jan 2013, there have been 23 new Allscripts Sunrise commitments made by Allscripts Healthcare Solutions, Inc. (MDRX) at existing client facilities or at new organizations globally.

Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 7:44AM CDT
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise 9% on the day.

Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.

Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.

Can The Uptrend Continue for Cardica (CRDC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 8:10AM CDT
Can The Uptrend Continue for Cardica (CRDC)?

LeMaitre Vascular (LMAT) Soars: Stock Adds 10.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 7:51AM CDT
LeMaitre Vascular, Inc. (LMAT) was a big mover last session, as its shares rose nearly 11% on the day.

Bio-Rad Unveils Vitamin-D Test in International Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 2:00PM CDT
Bio-Rad's(BIO) BioPlex 2200 system is the first and only fully-automated, random access multiplex testing system used for clinical diagnostic analyses.

Covidien Launches New PED to Treat Brain Aneurysm - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 12:40PM CDT
Combining Covidien Plc.'s (COV) clinically-proven braid design with a new delivery system, the new PED offers enhanced accuracy and control while performing advanced surgical procedures on the brain.

Strength Seen in TG Therapeutics, Inc. (TGTX) as Stock Rallies 12.94% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 7:44AM CDT
TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares surge nearly 13% on the day.

Greatbatch Touches a New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 4:00PM CDT
Impressive first-quarter 2014 results indicating double-digit bottom-line growth, strategic restructuring efforts along with accretive investments in sales and marketing led to the growth trajectory of Greatbatch, Inc. (GB).

CareFusion Reaches a New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 3:10PM CDT
Shares of CareFusion Corporation (CFN) have been on the rise since it reported strong third-quarter fiscal 2014 (ended Mar 31, 2014) results on May 5.

St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.

Medtronic's Micra Pacemaker Spells Success in Prelim Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 2:05PM CDT
Medtronic (MDT) posted preliminary results from the first human implant of the world's smallest pacemaker.

athenahealth Leads in Meaningful Use Stage 2 Attestations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:35PM CDT
athenahealth, Inc. (ATHN) revealed that its clients comprise 59.2% of the total providers in the U.S. who have successfully attested to Stage 2 of the Meaningful Use EHR incentive program as of May 31, 2014.

CareFusion Unveils MicroLap Surgical Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:20PM CDT
CareFusion's (CFN) MicroLap instruments avoid the need to close the incision site and leads to a virtually scar-less procedure.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Honeywell Aerospace Faces Securities Fraud Lawsuit

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

Angels on Call Sets Benchmark for Specialized Homecare

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Firmable's Tech Intelligence: New Edge in B2B Sales

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Decoding Love: The Real Patterns of Relationships

The Relationship Maze: More Than Meets the Eye Love ain't just a simple spark over a fancy dinner, let me tell you. In Dr. Bernadette Marson’s ‘The Relationship Code,’ she digs into seventy-seven elements gnawing at why relationships can crumble or thrive. It’s like a blueprint of human entanglements—a veritable explorer’s guide to the vast, wild creation we...

Endava Faces Securities Fraud Lawsuit: Investor Implications

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

LBT Unveils Game-Changing Cyclotron for Medical Advances

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...